Femasys Inc.
NCM: FEMYLive Quote
📈 ZcoreAI Score
Our AI model analyzes Femasys Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get FEMY Z-Score →About Femasys Inc.
Healthcare
Medical Instruments & Supplies
Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornual balloon catheter for selective fallopian tube evaluation; and FemChec, a controlled contrast-generating device for fallopian tube diagnosis. It also develops FemBloc, a non-surgical permanent birth control solution. The company offers its products to reproductive endocrinologists, gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
📊 Fundamental Analysis
Femasys Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
The company recently reported 39.9% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -455.8%, which indicates that capital utilization is currently under pressure.
At a current price of $0.40, FEMY currently trades near the bottom of its 52-week range (9%), indicating potential value or weakness (Range: $0.31 - $1.29).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$23.98M
Trailing P/E
--
Forward P/E
-1.12
Beta (5Y)
-2.28
52W High
$1.29
52W Low
$0.31
Avg Volume
718K
Day High
Day Low